New research links neighborhood-level environmental and social factors to higher asthma and COPD prevalence, highlighting the ...

For those with pre-existing conditions like asthma or COPD, particulate matter can trigger exacerbations and accelerate ...

Long COVID development may be influenced by severity of the initial COVID-19 illness and pre-existing respiratory conditions, including COPD and OSA.

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses the potential of tailored treatment strategies and the importance of smoking cessation.

Learn how dupilumab significantly improves quality of life in COPD patients with type 2 inflammation, according to phase 3 ...

Dupilumab, an injectable interleukin (IL)-4 and IL-13 pathway inhibitor, recently received FDA approval as the first-ever ...

The surprise finding hints that anti–acid reflux therapy may provide benefit in COPD, possibly by reducing micro-aspirations, ...

The Quake is a pipe-shaped oscillatory PEP device that bears ... [53] however there is little research in the COPD population and it is therefore difficult to define its role in clinical practice.

Shortness of breath, often dismissed as a harmless symptom of fatigue or stress, can be an alarming indicator of underlying ...

for the treatment of chronic obstructive pulmonary disease (“COPD”) will be presented at CHEST Annual Meeting (“CHEST”) 2024. The analyses are published in the CHEST Annual Meeting on-line ...

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...